Natrium Chloride Aguettant (Sodium Chloride)

Sodium Chloride, the active ingredient in Natrium Chloride Aguettant, is an electrolyte presented as a solution for injection for intravenous use. It helps replace fluid and electrolyte losses in patients who need volume expansion or correction of hyponatremia. GNH USA supplies Natrium Chloride Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Natrium Chloride Aguettant is used in clinical situations that require rapid restoration of extracellular fluid and electrolyte balance. - Hyponatremia: restores normal serum sodium levels in patients with low sodium concentrations. - Hypovolemia: expands intravascular volume to improve blood pressure and tissue perfusion. - Peri‑operative fluid management: maintains electrolyte balance and volume status during surgery. - Fluid and electrolyte replacement: corrects deficits caused by burns, diarrhea, or excessive sweating.

Adverse reactions may occur with any intravenous electrolyte solution.

Common Side Effects: - Hypernatremia: elevated serum sodium if administered excessively. - Fluid overload: signs of edema or pulmonary congestion. - Phlebitis: inflammation at the infusion site. - Injection site pain or irritation. - Hypertension: transient increase in blood pressure. - Electrolyte imbalance: shifts in potassium or calcium levels.

Serious or Rare Side Effects: - Severe hypernatremia leading to neurologic symptoms. - Pulmonary edema with respiratory distress. - Anaphylactic or severe allergic reaction. - Cardiac arrhythmias due to rapid electrolyte shifts. - Metabolic acidosis in extreme cases.

When using Natrium Chloride Aguettant, clinicians should consider several safety measures. - Assess baseline serum electrolytes: verify sodium and chloride levels before infusion. - Monitor fluid balance: track input, output, and weight to avoid overload. - Adjust infusion rate: use controlled rates, especially in patients with cardiac or renal impairment. - Avoid rapid large-volume bolus: limit to recommended clinical guidelines. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potential drug interactions may modify the safety or efficacy of Natrium Chloride Aguettant.

Major Interactions (Avoid): - Concurrent hypertonic saline solutions: may cause severe hypernatremia. - Potassium chloride infusions given simultaneously: risk of hyperkalemia and precipitation. - Diuretics that cause rapid sodium loss: may exacerbate electrolyte disturbances.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance potassium retention. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can affect renal sodium handling. - Corticosteroids: may increase sodium retention and fluid volume.